Patents by Inventor Meiqin Wang

Meiqin Wang has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20200108119
    Abstract: Disclosed are methods to treat allergic conditions, including pulmonary and non-pulmonary conditions, in a subject by administering a composition that inhibits Pim kinase. Also disclosed are methods to treat allergic conditions in a subject by administering a composition that induces expression of Runx3.
    Type: Application
    Filed: June 26, 2019
    Publication date: April 9, 2020
    Inventors: Erwin W. Gelfand, Meiqin Wang
  • Patent number: 10369194
    Abstract: Disclosed are methods to treat allergic conditions, including pulmonary and non-pulmonary conditions, in a subject by administering a composition that inhibits Pim kinase. Also disclosed are methods to treat allergic conditions in a subject by administering a composition that induces expression of Runx3.
    Type: Grant
    Filed: July 31, 2017
    Date of Patent: August 6, 2019
    Assignee: National Jewish Health
    Inventors: Erwin W. Gelfand, Meiqin Wang
  • Publication number: 20190127740
    Abstract: The present invention relates to methods and compositions for treating and/or preventing allergic diseases or conditions by inhibiting one or more components of the steroidogenic pathway.
    Type: Application
    Filed: September 11, 2018
    Publication date: May 2, 2019
    Inventors: Erwin W. Gelfand, Meiqin Wang, Yi Jia
  • Patent number: 10100309
    Abstract: The present invention relates to methods and compositions for treating and/or preventing allergic diseases or conditions by inhibiting one or more components of the steroidogenic pathway.
    Type: Grant
    Filed: November 10, 2016
    Date of Patent: October 16, 2018
    Assignee: National Jewish Health
    Inventors: Erwin W. Gelfand, Meiqin Wang, Yi Jia
  • Publication number: 20180015143
    Abstract: Disclosed are methods to treat allergic conditions, including pulmonary and non-pulmonary conditions, in a subject by administering a composition that inhibits Pim kinase. Also disclosed are methods to treat allergic conditions in a subject by administering a composition that induces expression of Runx3.
    Type: Application
    Filed: July 31, 2017
    Publication date: January 18, 2018
    Inventors: Erwin W. Gelfand, Meiqin Wang
  • Publication number: 20170191063
    Abstract: The present invention relates to methods and compositions for treating and/or preventing allergic diseases or conditions by inhibiting one or more components of the steroidogenic pathway.
    Type: Application
    Filed: November 10, 2016
    Publication date: July 6, 2017
    Inventors: Erwin W. Gelfand, Meiqin Wang, Yi Jia
  • Patent number: 9534221
    Abstract: The present invention relates to methods and compositions for treating and/or preventing allergic diseases or conditions by inhibiting one or more components of the steroidogenic pathway.
    Type: Grant
    Filed: January 22, 2014
    Date of Patent: January 3, 2017
    Assignee: National Jewish Health
    Inventors: Erwin W. Gelfand, Meiqin Wang, Yi Jia
  • Publication number: 20140377310
    Abstract: Disclosed are methods to treat allergic conditions, including pulmonary and non-pulmonary conditions, in a subject by administering a composition that inhibits Pim kinase. Also disclosed are methods to treat allergic conditions in a subject by administering a composition that induces expression of Runx3.
    Type: Application
    Filed: June 30, 2014
    Publication date: December 25, 2014
    Inventors: Erwin W. Gelfand, Meiqin Wang
  • Patent number: 8802099
    Abstract: Disclosed are methods to treat allergic conditions, including pulmonary and non-pulmonary conditions, in a subject by administering a composition that inhibits Pim kinase. Also disclosed are methods to treat allergic conditions in a subject by administering a composition that induces expression of Runx3.
    Type: Grant
    Filed: November 10, 2011
    Date of Patent: August 12, 2014
    Assignee: National Jewish Health
    Inventors: Erwin W. Gelfand, Meiqin Wang
  • Publication number: 20140206749
    Abstract: The present invention relates to methods and compositions for treating and/or preventing allergic diseases or conditions by inhibiting one or more components of the steroidogenic pathway.
    Type: Application
    Filed: January 22, 2014
    Publication date: July 24, 2014
    Applicant: National Jewish Health
    Inventors: Erwin W. Gelfand, Meiqin Wang, Yi Jia
  • Publication number: 20120114663
    Abstract: Disclosed are methods to treat allergic conditions, including pulmonary and non-pulmonary conditions, in a subject by administering a composition that inhibits Pim kinase. Also disclosed are methods to treat allergic conditions in a subject by administering a composition that induces expression of Runx3.
    Type: Application
    Filed: November 10, 2011
    Publication date: May 10, 2012
    Applicant: NATIONAL JEWISH HEALTH
    Inventors: Erwin W. Gelfand, Meiqin Wang